News Focus
News Focus
icon url

semi_infinite

01/06/23 1:18 PM

#27060 RE: DewDiligence #27049

Interesting micro fiber technology. There should be a good market if it works better than cadaver grafts. Reminds me of Vericel for cartilage (no overlap).
icon url

DewDiligence

02/03/23 6:50 AM

#27242 RE: DewDiligence #27049

ZBH reports 4Q22 results—issues 2023 guidance:

https://finance.yahoo.com/news/zimmer-biomet-announces-fourth-quarter-113000895.html

2023 non-GAAP EPS guidance is $6.95-7.15, which is 1-4% growth vs 2022 non-GAAP EPS of $6.89.